BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 7734029)

  • 1. In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides.
    González-López NM; Guerra-Acero-Turizo LM; Blanco-Medina I; Barragán-Cárdenas AC; Ramírez-Celis DA; Martínez-Ramírez JA; Fierro-Medina R; García-Castañeda JE; Rivera-Monroy ZJ
    Biomed Chromatogr; 2023 Dec; 37(12):e5741. PubMed ID: 37688464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling ceramide dynamics: Shedding light on healthy aging in growth hormone-releasing hormone knockout mice.
    Lasher AT; Wang L; Hyun J; Summers SA; Sun LY
    Aging Cell; 2024 May; ():e14226. PubMed ID: 38808779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating age-related changes in somatotrophic hormones, sleep, and cognition.
    Vitiello MV; Schwartz RS; Moe KE; Mazzoni G; Merriam GR
    Dialogues Clin Neurosci; 2001 Sep; 3(3):229-36. PubMed ID: 22034239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging.
    Thorner MO; Chapman IM; Gaylinn BD; Pezzoli SS; Hartman ML
    Recent Prog Horm Res; 1997; 52():215-44; discussion 244-6. PubMed ID: 9238854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidism.
    Pimentel-Filho FR; Ramos-Dias JC; Ninno FB; Façanha CF; Liberman B; Lengyel AM
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):295-300. PubMed ID: 9156038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells.
    Lei T; Buchfelder M; Fahlbusch R; Adams EF
    J Mol Endocrinol; 1995 Feb; 14(1):135-8. PubMed ID: 7772238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.
    Grugni G; Guzzaloni G; Morabito F
    J Endocrinol Invest; 2001 May; 24(5):340-8. PubMed ID: 11407654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2.
    Veldhuis JD; Evans WS; Bowers CY; Anderson S
    Endocrine; 2001 Feb; 14(1):45-62. PubMed ID: 11322501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone-releasing peptides: clinical and basic aspects.
    Argente J; García-Segura LM; Pozo J; Chowen JA
    Horm Res; 1996; 46(4-5):155-9. PubMed ID: 8950613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-releasing peptides.
    Ghigo E; Arvat E; Muccioli G; Camanni F
    Eur J Endocrinol; 1997 May; 136(5):445-60. PubMed ID: 9186261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood.
    Micic D; Popovic V; Kendereski A; Macut D; Casanueva FF; Dieguez C
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):191-4. PubMed ID: 7734029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
    Cordido F; Peñalva A; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome.
    Leal-Cerro A; Pumar A; Garcia-Garcia E; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):649-54. PubMed ID: 7828354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
    Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level.
    Popovic V; Damjanovic S; Micic D; Djurovic M; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1995 Mar; 80(3):942-7. PubMed ID: 7883854
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.